Table 4. Association between presence of narrow-caliber esophagus and symptomatic, endoscopic, and histologica response to steroidb treatment.
| Unadjusted odds ratio (95% CI) | Adjustedc odds ratio (95% CI) | |
|---|---|---|
| Symptom response to steroids (n, %) | 0.22 (0.09-0.53) | 0.28 (0.08-0.96) |
| EGD response to steroids (n, %) | 0.33 (0.15-0.70) | 0.31 (0.10-0.90) |
| Histologic response to steroids (n, %) | 0.29 (0.13-0.64) | 0.27 (0.09-0.74) |
Defined as <15 eosinophils/hpf.
Defined as any topical swallowed corticosteroid formulation.
Adjusted for symptom duration, history of dilation, and age at biopsy.